ASX - By Stock
|
OPL |
Re:
Ann: Cleansing notice
|
|
Medify
|
2 |
217 |
0 |
21:10 |
21:10 |
ASX - By Stock
|
2
|
217
|
0
|
|
ASX - By Stock
|
MKR |
Re:
Ann: MKR Targeting Near-Term Gold and Silver Production in Cobar
|
|
Medify
|
14 |
3.0K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
14
|
3.0K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Proposed issue of securities - OPL
|
|
Medify
|
1 |
286 |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
1
|
286
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl receives non-binding offer for its Opin business
|
|
Medify
|
14 |
3.0K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
14
|
3.0K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Opyl matters
|
|
Medify
|
9 |
1.4K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
9
|
1.4K
|
2
|
|
ASX - By Stock
|
OPL |
Re:
Opyl matters
|
|
Medify
|
9 |
1.4K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
9
|
1.4K
|
2
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Opyl receives non-binding offer for its Opin business
|
|
Medify
|
14 |
3.0K |
5 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
14
|
3.0K
|
5
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Company Secretary Appointment/Resignation
|
|
Medify
|
31 |
6.9K |
1 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
31
|
6.9K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Company Secretary Appointment/Resignation
|
|
Medify
|
31 |
6.9K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
31
|
6.9K
|
2
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Company Secretary Appointment/Resignation
|
|
Medify
|
31 |
6.9K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
31
|
6.9K
|
2
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Company Secretary Appointment/Resignation
|
|
Medify
|
31 |
6.9K |
2 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
31
|
6.9K
|
2
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Request for Trading Halt
|
|
Medify
|
5 |
876 |
7 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
5
|
876
|
7
|
|
ASX - By Stock
|
OPL |
Re:
Opyl matters
|
|
Medify
|
9 |
1.4K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
9
|
1.4K
|
0
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Company Secretary Appointment/Resignation
|
|
Medify
|
31 |
6.9K |
1 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
31
|
6.9K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Company Secretary Appointment/Resignation
|
|
Medify
|
31 |
6.9K |
0 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
31
|
6.9K
|
0
|
|
ASX - By Stock
|
MKR |
Re:
Potential change
|
|
Medify
|
20 |
7.2K |
0 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
20
|
7.2K
|
0
|
|
ASX - By Stock
|
MKR |
Re:
Potential change
|
|
Medify
|
20 |
7.2K |
0 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
20
|
7.2K
|
0
|
|
ASX - By Stock
|
MKR |
Re:
Potential change
|
|
Medify
|
20 |
7.2K |
1 |
16/03/24 |
16/03/24 |
ASX - By Stock
|
20
|
7.2K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Resignation of Chair
|
|
Medify
|
2 |
464 |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
2
|
464
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Opyl matters
|
|
Medify
|
9 |
1.4K |
1 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
9
|
1.4K
|
1
|
|
ASX - By Stock
|
OPL |
Opyl matters
|
|
Medify
|
9 |
1.4K |
1 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
9
|
1.4K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
PFAS and beyond
|
|
Medify
|
13 |
2.7K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
13
|
2.7K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
PO3 notches 1 year suspension anniversary
|
|
Medify
|
25 |
6.0K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
25
|
6.0K
|
1
|
|
ASX - By Stock
|
OPL |
Re:
Ann: OPL - Appendix 4D & Half Year Results
|
|
Medify
|
1 |
375 |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1
|
375
|
2
|
|
ASX - By Stock
|
PO3 |
Re:
PO3 notches 1 year suspension anniversary
|
|
Medify
|
25 |
6.0K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
25
|
6.0K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
PO3 notches 1 year suspension anniversary
|
|
Medify
|
25 |
6.0K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
25
|
6.0K
|
2
|
|
ASX - By Stock
|
PO3 |
Re:
PO3 notches 1 year suspension anniversary
|
|
Medify
|
25 |
6.0K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
25
|
6.0K
|
0
|
|
ASX - By Stock
|
PO3 |
Re:
PO3 notches 1 year suspension anniversary
|
|
Medify
|
25 |
6.0K |
2 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
25
|
6.0K
|
2
|
|
ASX - By Stock
|
PO3 |
PO3 notches 1 year suspension anniversary
|
|
Medify
|
25 |
6.0K |
0 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
25
|
6.0K
|
0
|
|
ASX - By Stock
|
OPL |
Re:
Ann: Application for quotation of securities - OPL
|
|
Medify
|
1 |
408 |
4 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
1
|
408
|
4
|
|
ASX - By Stock
|
OPL |
Did OPL predict CSL Phase 3 failure?
|
|
Medify
|
0 |
244 |
7 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
0
|
244
|
7
|
|
ASX - By Stock
|
OPL |
Money man swoops on OPL
|
|
Medify
|
0 |
251 |
2 |
09/02/24 |
09/02/24 |
ASX - By Stock
|
0
|
251
|
2
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: PFAS Testing Update
|
|
Medify
|
68 |
20K |
2 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
68
|
20K
|
2
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: PFAS Testing Update
|
|
Medify
|
68 |
20K |
0 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
68
|
20K
|
0
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: PFAS Testing Update
|
|
Medify
|
68 |
20K |
0 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
68
|
20K
|
0
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: PFAS Testing Update
|
|
Medify
|
68 |
20K |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
68
|
20K
|
2
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: PFAS Testing Update
|
|
Medify
|
68 |
20K |
1 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
68
|
20K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: PFAS Testing Update
|
|
Medify
|
68 |
20K |
1 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
68
|
20K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: PFAS Testing Update
|
|
Medify
|
68 |
20K |
1 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
68
|
20K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: PFAS Testing Update
|
|
Medify
|
68 |
20K |
2 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
68
|
20K
|
2
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: PFAS Testing Update
|
|
Medify
|
68 |
20K |
1 |
26/11/23 |
26/11/23 |
ASX - By Stock
|
68
|
20K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Medify
|
41 |
10K |
2 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
41
|
10K
|
2
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Medify
|
41 |
10K |
1 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
41
|
10K
|
1
|
|
ASX - By Stock
|
IPT |
Re:
Ann: Resource Connect Asia Presentation
|
|
Medify
|
21 |
7.1K |
2 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
21
|
7.1K
|
2
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Medify
|
41 |
10K |
1 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
41
|
10K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Medify
|
41 |
10K |
1 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
41
|
10K
|
1
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Appendix 4E Preliminary Final Results - 30 June 2023
|
|
Medify
|
3 |
1.1K |
2 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
3
|
1.1K
|
2
|
|
ASX - By Stock
|
IPT |
Re:
IPT possible 100 bagger?
|
|
Medify
|
787 |
319K |
11 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
787
|
319K
|
11
|
|
ASX - By Stock
|
KNG |
Re:
KNG - General Thread
|
|
Medify
|
252 |
63K |
4 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
252
|
63K
|
4
|
|
ASX - By Stock
|
PO3 |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Medify
|
41 |
10K |
3 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
41
|
10K
|
3
|
|